Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Blood System Drugs>Anticoagulant and Antiplatelet Drugs>Cilostazol
Cilostazol
  • Cilostazol

Cilostazol NEW

Price $53 $77
Package 50mg 100mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: Cilostazol CAS No.: 73963-72-1
Purity: 99.87% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameCilostazol
DescriptionCilostazol (OPC 21) is a Phosphodiesterase 3 Inhibitor. The mechanism of action of cilostazol is as a Phosphodiesterase 3 Inhibitor.
In vivoCilostazol induces relaxation of vascular smooth muscle and causes vasodilation. It inhibits the expression of monocyte chemotactic protein-1 (MCP-1) induced by cytokines. Additionally, Cilostazol reduces plasma triglycerides and increases high-density lipoprotein (HDL) levels. The vasodilatory and antithrombotic effects of Cilostazol are primarily due to the inhibition of phosphodiesterase 3 (PDE3) and the subsequent elevation of intracellular cyclic adenosine monophosphate (cAMP) levels. It also inhibits platelet aggregation and adenosine uptake.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 15 mg/mL (40.6 mM), Sonication is recommended.
Ethanol : 3.7 mg/mL (10 mM)
KeywordsOPC-21 | late | Cilostazol | fibrogenesis | OPC-13013 | cardiovascular | inhibit | OPC21 | injury | hepatic | OPC13013 | Phosphodiesterase (PDE) | Autophagy | Inhibitor
Inhibitors RelatedStavudine | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | Taurine | Curcumin | Oxyresveratrol | Paeonol | Naringin | Gefitinib
Related Compound LibrariesAnti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$77.00/100mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-19
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-11-13
$0.00/1KG
VIP1Y
Hangzhou Hyper Chemicals Limited
2024-06-13
$0.00/25KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-08-02
$1.10/1g
VIP4Y
Dideu Industries Group Limited
2021-08-04
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
$0.00/1KG
VIP4Y
WUHAN FORTUNA CHEMICAL CO., LTD
2021-06-15
$0.00/1KG
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
2020-11-24
$7.00/1kg
VIP7Y
Career Henan Chemical Co
2018-12-21
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-08
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hills
INQUIRY